title: Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction.
abstract: OBJECTIVE
  The aim of the study reported here was to assess the efficacy of an artificial tear emulsion for the treatment of dry eye associated with meibomian gland dysfunction (MGD).
  
  
  METHODS
  At five clinics, patients completed a 1-week treatment with their habitual topical therapy and then a 4-week treatment with open-label study medication: Systane® Balance Lubricant Eye Drops (Alcon, Alcon Inc, Fort Worth, TX, USA). Subjective assessments included a preference survey, the Impact of Dry Eye in Everyday Life questionnaire, and the Work Productivity and Activity Impairment questionnaire. Objective assessments by unmasked investigators included visual acuity, meibomian gland expression and dropout, tear film breakup time, corneal staining, and dosing frequency.
  
  
  RESULTS
  At baseline, the 49 patients had mean meibomian gland expression grades and gland dropout that indicated mild to moderate MGD. Patients administered their habitual therapy 2.5 ± 1.3 times per day. After 4 weeks of study medication, the Impact of Dry Eye in Everyday Life questionnaire results indicated statistically and clinically significant improvements. Fewer than half of the participants were employed, limiting the usefulness of the Work Productivity and Activity Impairment questionnaire. Visual acuity remained statistically similar, while corneal staining and tear film breakup time improved significantly (P < 0.05) but modestly. The outcomes were achieved with 1.9 ± 1.1 doses per day of study medication, a significantly lower frequency than the habitual frequency (P < 0.001). The most common medication-related adverse event was blurred vision (3/49 patients, 6.1%). At study conclusion, 27/44 (61.4%) survey respondents preferred the study medication to their habitual therapy.
  
  
  CONCLUSIONS
  The artificial tear emulsion was effective for treating the signs and symptoms of dry eye in MGD patients.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, IA USA.
authors.forename: Christine W
authors.initials: CW
authors.lastname: Sindt
authors.forename: Gary N
authors.initials: GN
authors.lastname: Foulks
keywords: Impact on Dry Eye in Everyday Life; MGD; Work Productivity and Activity Impairment; corneal staining; ophthalmic solutions; tear film breakup time
references.citation: Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1922-9
references.pmid: 21450913
references.citation: Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):2050-64
references.pmid: 21450919
references.citation: Cornea. 1991 Jul;10(4):277-85
references.pmid: 1889213
references.citation: Ophthalmology. 2008 May;115(5):911-5
references.pmid: 18452765
references.citation: Eye (Lond). 2003 Jan;17(1):79-83
references.pmid: 12579175
references.citation: Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1917-21
references.pmid: 21450912
references.citation: Cornea. 2006 Dec;25(10):1162-7
references.pmid: 17172891
references.citation: Acta Ophthalmol (Copenh). 1985 Dec;63(6):698-700
references.pmid: 2420147
references.citation: CLAO J. 1995 Oct;21(4):221-32
references.pmid: 8565190
references.citation: Am J Ophthalmol. 2007 Oct;144(4):533-40
references.pmid: 17686450
references.citation: Cornea. 2004 Nov;23(8):762-70
references.pmid: 15502475
references.citation: Value Health. 2005 Mar-Apr;8(2):168-74
references.pmid: 15804325
references.citation: Cornea. 2011 Apr;30(4):379-87
references.pmid: 21045640
references.citation: Arch Ophthalmol. 2004 Nov;122(11):1667-74
references.pmid: 15534128
references.citation: Clin Ophthalmol. 2011;5:783-90
references.pmid: 21750611
references.citation: Ocul Surf. 2007 Apr;5(2):75-92
references.pmid: 17508116
references.citation: Cornea. 2006 Feb;25(2):171-5
references.pmid: 16371776
references.citation: J Ocul Pharmacol Ther. 2010 Aug;26(4):347-53
references.pmid: 20653478
references.citation: Clin Ther. 2008 Feb;30(2):393-404
references.pmid: 18343277
references.citation: Pharmacoeconomics. 1993 Nov;4(5):353-65
references.pmid: 10146874
references.citation: Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1930-7
references.pmid: 21450914
references.citation: Cornea. 2013 Mar;32(3):242-7
references.pmid: 22580439
references.citation: Optom Vis Sci. 2000 Jul;77(7):357-63
references.pmid: 10939313
references.citation: Pharmacoeconomics. 2010;28(12):1097-107
references.pmid: 21080735
references.citation: Ophthalmology. 2003 Jun;110(6):1096-101
references.pmid: 12799232
references.citation: Optom Vis Sci. 2008 Aug;85(8):699-707
references.pmid: 18677226
references.citation: Ophthalmology. 2009 Nov;116(11):2058-63.e1
references.pmid: 19744718